Stay updated on PD-1 Inhibitor & Chemo With Radiation in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibitor & Chemo With Radiation in Advanced NSCLC Clinical Trial page.

Latest updates to the PD-1 Inhibitor & Chemo With Radiation in Advanced NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference0.8%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.2.SummaryDifference1%
- Check71 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check85 days agoChange DetectedThe webpage has been updated to reflect a new version (v2.15.0) and includes the names of principal investigators and collaborators associated with a study on advanced non-small cell lung cancer. Additionally, specific details about the inclusion criteria for the study have been added.SummaryDifference35%
- Check93 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to PD-1 Inhibitor & Chemo With Radiation in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibitor & Chemo With Radiation in Advanced NSCLC Clinical Trial page.